MissionIR Articles
Original content written and distributed as part of our ongoing relationships.
-
VistaGen Therapeutics (VSTA) Awarded $3,700,000 NIH Drug Development Grant for LeadEpilepsy Drug Candidate
Burlingame, CA, May 24, 2005 /PRNewswire/ — VistaGen Therapeutics, Inc., a development stage biopharmaceutical company focused on discovering, developing and commercializing novel small molecule and protein therapeutics for Central Nervous System (CNS) disorders and metabolic…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS) Spotlighted in NetworkNewsWire Editorial on AI-Powered Wearables
- SuperCom Ltd. (NASDAQ: SPCB) CEO Presents Key Milestones and Strategic Initiatives at Investor Summit Virtual
- MissionIRNewsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Appoints Former Live Nation Europe President Simon Lewis to Lead Concerts.com, TicketStub.com Rollout
- MissionIRNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Highlighted in Northland Capital Markets Report on AI Integration With Red Cat Black Widow Drone
- D-Wave Quantum Inc. (NYSE: QBTS) Announces First-Ever Qubits Japan 2025 Quantum Computing User Conference